PL2408446T3 - Zastosowanie kompozycji farmaceutycznych zawierających mesembrenon - Google Patents
Zastosowanie kompozycji farmaceutycznych zawierających mesembrenonInfo
- Publication number
- PL2408446T3 PL2408446T3 PL10710448T PL10710448T PL2408446T3 PL 2408446 T3 PL2408446 T3 PL 2408446T3 PL 10710448 T PL10710448 T PL 10710448T PL 10710448 T PL10710448 T PL 10710448T PL 2408446 T3 PL2408446 T3 PL 2408446T3
- Authority
- PL
- Poland
- Prior art keywords
- mesembrenone
- pharmaceutical compositions
- compositions containing
- pharmaceutical
- containing mesembrenone
- Prior art date
Links
- HDNHBCSWFYFPAN-IRXDYDNUSA-N Mesembrenone Chemical compound C1=C(OC)C(OC)=CC=C1[C@@]1(C=CC(=O)C2)[C@H]2N(C)CC1 HDNHBCSWFYFPAN-IRXDYDNUSA-N 0.000 title 1
- HDNHBCSWFYFPAN-UHFFFAOYSA-N mesembrenone Natural products C1=C(OC)C(OC)=CC=C1C1(C=CC(=O)C2)C2N(C)CC1 HDNHBCSWFYFPAN-UHFFFAOYSA-N 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/36—Caryophyllaceae (Pink family), e.g. babysbreath or soapwort
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/12—Antidiarrhoeals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/08—Antiseborrheics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/04—Drugs for disorders of the muscular or neuromuscular system for myasthenia gravis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Physical Education & Sports Medicine (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Epidemiology (AREA)
- Rheumatology (AREA)
- Pulmonology (AREA)
- Alternative & Traditional Medicine (AREA)
- Mycology (AREA)
- Heart & Thoracic Surgery (AREA)
- Microbiology (AREA)
- Cardiology (AREA)
- Dermatology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Oncology (AREA)
- Psychiatry (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Psychology (AREA)
- Vascular Medicine (AREA)
- Hospice & Palliative Care (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ZA200902003 | 2009-03-20 | ||
| PCT/IB2010/051132 WO2010106494A1 (en) | 2009-03-20 | 2010-03-16 | Use of pharmaceutical compositions containing mesembrenone |
| EP10710448.1A EP2408446B1 (en) | 2009-03-20 | 2010-03-16 | Use of pharmaceutical compositions containing mesembrenone |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL2408446T3 true PL2408446T3 (pl) | 2020-03-31 |
Family
ID=42167479
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL10710448T PL2408446T3 (pl) | 2009-03-20 | 2010-03-16 | Zastosowanie kompozycji farmaceutycznych zawierających mesembrenon |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US8552051B2 (pl) |
| EP (1) | EP2408446B1 (pl) |
| AU (1) | AU2010224485B2 (pl) |
| DK (1) | DK2408446T3 (pl) |
| ES (1) | ES2759675T3 (pl) |
| PL (1) | PL2408446T3 (pl) |
| PT (1) | PT2408446T (pl) |
| WO (1) | WO2010106494A1 (pl) |
| ZA (1) | ZA201106703B (pl) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2408460B1 (en) | 2009-03-20 | 2018-09-26 | HG&H Pharmaceuticals (Pty) Limited | Sceletium extract and uses thereof |
| GB201101075D0 (en) | 2011-01-21 | 2011-03-09 | Labminds Ltd | Automated solution dispenser |
| BR112013019335B1 (pt) | 2011-02-07 | 2022-05-31 | Scipharm Sàrl | Nova composição, método para aumentar o nível de camp em um célula e combinação terapêutica, para o tratamento da fibrose cística |
| BR112015019276A2 (pt) | 2013-02-19 | 2017-07-18 | Pfizer | compostos de azabenzimidazol como inibidores de isoenzimas de pde4 para o tratamento de distúrbios do snc e outros distúrbios |
| WO2015048590A1 (en) * | 2013-09-27 | 2015-04-02 | Sher Justin | Nutraceutical compositon for pde4 inhibition, enhanced dopamine metabolism and long term potentiation |
| WO2015130994A1 (en) * | 2014-02-28 | 2015-09-03 | Tripp Matthew L | Phosphodiesterase-4 inhibiting phytochemical compositions |
| WO2016012896A1 (en) | 2014-07-24 | 2016-01-28 | Pfizer Inc. | Pyrazolopyrimidine compounds |
| MD20170011A2 (ro) | 2014-08-06 | 2017-08-31 | Pfizer Inc. | Compuşi imidazopiridazinici |
| GB2553672A (en) | 2015-02-06 | 2018-03-14 | Labminds Ltd | Automated solution dispenser |
| WO2017089347A1 (en) | 2015-11-25 | 2017-06-01 | Inserm (Institut National De La Sante Et De La Recherche Medicale) | Methods and pharmaceutical compositions for the treatment of braf inhibitor resistant melanomas |
| AU2018307730B9 (en) | 2017-07-26 | 2024-02-15 | Hg&H Pharmaceuticals (Pty) Ltd | Mesembrenol and/or mesembranol for prophylaxis and treatment of patients suffering from epilepsy and associated diseases |
| WO2021086345A1 (en) * | 2019-10-30 | 2021-05-06 | Plant Synergy Inc. | High yield extraction method for and products of kanna plants |
| US10864239B1 (en) | 2019-10-30 | 2020-12-15 | Plant Synergy Inc. | High yield extraction method for and products of kanna plants |
| US20250051277A1 (en) | 2021-10-29 | 2025-02-13 | Sensorium Therapeutics, Inc. | Delivery of therapeutic alkaloid compounds |
| US12410128B1 (en) | 2022-04-15 | 2025-09-09 | Sensorium Therapeutics, Inc. | Therapeutic alkaloid compounds |
| GB2643843A (en) * | 2023-03-28 | 2026-03-04 | Univ Stellenbosch | Composition comprising a sceletium extract and uses thereof |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3604112A1 (de) | 1986-02-10 | 1987-08-13 | Bernhard Dr Janiak | Pflanzenextrakte von mesembryanthemaceen sowie solche enthaltende schaedlingsbekaempfungsmittel und arzneimittel |
| US6271001B1 (en) | 1995-03-23 | 2001-08-07 | Bio Polymers Pty. Ltd. | Cultured plant cell gums for food, pharmaceutical, cosmetic and industrial applications |
| ZA974576B (en) | 1996-06-04 | 1998-02-04 | Farmarc Nederland Bv | Pharmaceutical composition. |
| SE9804064D0 (sv) | 1998-11-25 | 1998-11-25 | A & Science Invest Ab | Medicinal product and method for treatment of conditions affecting neural stem cells or progenitor cells |
| JP2003523741A (ja) | 2000-02-01 | 2003-08-12 | ヒューマン ジノーム サイエンシーズ， インコーポレイテッド | Ｂｃｌ−２様ポリヌクレオチド、ポリペプチドおよび抗体 |
| GB0111579D0 (en) * | 2001-05-11 | 2001-07-04 | Holford & Associates Ltd | Oral supplement |
| WO2004032851A2 (en) | 2002-10-04 | 2004-04-22 | The Regents Of The University Of California | Screening and therapeutic methods relating to neurogenesis |
| DK1583541T3 (da) | 2002-11-20 | 2011-04-11 | Neuronova Ab | Forbindelser og fremgangsmåder til at øge neurogenese |
| US6969702B2 (en) * | 2002-11-20 | 2005-11-29 | Neuronova Ab | Compounds and methods for increasing neurogenesis |
| US20040185429A1 (en) | 2002-12-09 | 2004-09-23 | Judith Kelleher-Andersson | Method for discovering neurogenic agents |
| US20040254152A1 (en) | 2003-04-17 | 2004-12-16 | Monje Michelle L. | Prevention of deficits in neurogenesis with anti-inflammatory agents |
| US7763588B2 (en) | 2003-06-13 | 2010-07-27 | The Salk Institute For Biological Studies | Method for increasing cognitive function and neurogenesis |
| WO2005017189A2 (en) | 2003-08-05 | 2005-02-24 | University Of Florida Research Foundation, Inc. | Neural cell assay |
| EP1771435A4 (en) * | 2004-06-19 | 2008-02-13 | Human Biomolecular Res Inst | MODULATORS OF NEUROTRANSMITTERS OF THE CENTRAL NERVOUS SYSTEM |
| EP2408460B1 (en) | 2009-03-20 | 2018-09-26 | HG&H Pharmaceuticals (Pty) Limited | Sceletium extract and uses thereof |
-
2010
- 2010-03-16 PL PL10710448T patent/PL2408446T3/pl unknown
- 2010-03-16 AU AU2010224485A patent/AU2010224485B2/en active Active
- 2010-03-16 DK DK10710448T patent/DK2408446T3/da active
- 2010-03-16 ES ES10710448T patent/ES2759675T3/es active Active
- 2010-03-16 EP EP10710448.1A patent/EP2408446B1/en active Active
- 2010-03-16 US US13/256,686 patent/US8552051B2/en active Active
- 2010-03-16 WO PCT/IB2010/051132 patent/WO2010106494A1/en not_active Ceased
- 2010-03-16 PT PT107104481T patent/PT2408446T/pt unknown
-
2011
- 2011-09-13 ZA ZA2011/06703A patent/ZA201106703B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP2408446A1 (en) | 2012-01-25 |
| ZA201106703B (en) | 2012-05-30 |
| AU2010224485B2 (en) | 2014-04-17 |
| DK2408446T3 (da) | 2019-12-09 |
| US8552051B2 (en) | 2013-10-08 |
| EP2408446B1 (en) | 2019-09-11 |
| ES2759675T3 (es) | 2020-05-11 |
| US20120041045A1 (en) | 2012-02-16 |
| PT2408446T (pt) | 2019-12-18 |
| WO2010106494A1 (en) | 2010-09-23 |
| AU2010224485A1 (en) | 2011-10-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ZA201106703B (en) | Use of pharmaceutical compositions containing mesembrenone | |
| PT2482812T (pt) | Composições farmacêuticas compreendendo bi-1356 e metformina | |
| SG2014012405A (en) | Pharmaceutical compositions | |
| IL215451A0 (en) | Pharmaceutical composition | |
| EP2379077A4 (en) | PHARMACEUTICAL COMPOSITION | |
| IL215497A0 (en) | Oxadiazile derivatives and pharmaceutical compositions containing them | |
| ZA201203719B (en) | Pharmaceutical compositions of sevelamer | |
| EP2552447A4 (en) | STABLE PHARMACEUTICAL COMPOSITION OF IMATINIB | |
| ZA201107122B (en) | Stable pharmaceutical compositions of diclofenac | |
| PL2391353T3 (pl) | Kompozycje farmaceutyczne trimetazydyny | |
| EP2515880A4 (en) | NEW PHARMACEUTICAL COMPOSITIONS OF RANOLAZINE | |
| ZA201200659B (en) | Pharmaceutical composition of isoniazid | |
| PT2471520T (pt) | Composições farmacêuticas de levetiracetam | |
| GB0902648D0 (en) | Pharmaceutical compounds and compositions | |
| IL219018A (en) | Radzolid Pharmaceuticals and Uses | |
| GB0908317D0 (en) | Pharmaceutical compounds and compositions | |
| PL2407159T3 (pl) | Kompozycje farmaceutyczne olmesartanu | |
| ZA201107054B (en) | Use of atorvastatin lactols as medicaments | |
| PL2277511T3 (pl) | Kompozycje farmaceutyczne lewetiracetamu o przedłużonym uwalnianiu | |
| GB0919650D0 (en) | Pharmaceutical composition | |
| ZA201200531B (en) | Pharmaceutical composition of rifampicin | |
| PL2519261T3 (pl) | Płynna kompozycja farmaceutyczna doustna nifedypiny | |
| HU0900698D0 (en) | Pharmaceutical compositions of enhanced stability | |
| GB0908069D0 (en) | Pharmaceutical compounds and compositions | |
| GB0903945D0 (en) | Pharmaceutical compounds and compositions |